Trial · NCT06956885
Registered outcomes77
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 20 of 77
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Proportion of patients experiencing one or more flares | At 2 years | According to the Gaffo's criteria |
| Secondary | Proportion of patients experiencing one or more flares | At 6 months | According to both the Gaffo's criteria and the patient-reported Gout Attack Intensity Score (GAIS) |
| Secondary | Proportion of patients experiencing one or more flares | At 12 months | According to both the Gaffo's criteria and the patient-reported Gout Attack Intensity Score (GAIS) |
| Secondary | Proportion of patients experiencing one or more flares | At 18 months | According to both the Gaffo's criteria and the patient-reported Gout Attack Intensity Score (GAIS) |
| Secondary | Proportion of patients experiencing one or more flares | At 30 months | According to both the Gaffo's criteria and the patient-reported Gout Attack Intensity Score (GAIS) |
| Secondary | Proportion of patients experiencing one or more flares | At 36 months | According to both the Gaffo's criteria and the patient-reported Gout Attack Intensity Score (GAIS) |
| Secondary | Mean flare rates | At 6 months | According to both the Gaffo's criteria and the patient-reported Gout Attack Intensity Score (GAIS) |
| Secondary | Mean flare rates | At 12 months | According to both the Gaffo's criteria and the patient-reported Gout Attack Intensity Score (GAIS) |
| Secondary | Mean flare rates | At 18 months | According to both the Gaffo's criteria and the patient-reported Gout Attack Intensity Score (GAIS) |
| Secondary | Mean flare rates | At 24 months | According to both the Gaffo's criteria and the patient-reported Gout Attack Intensity Score (GAIS) |
| Secondary | Mean flare rates | At 30 months | According to both the Gaffo's criteria and the patient-reported Gout Attack Intensity Score (GAIS) |
| Secondary | Mean flare rates | At 36 months | According to both the Gaffo's criteria and the patient-reported Gout Attack Intensity Score (GAIS) |
| Secondary | US features of gout at MPT1s | At 6 months | Double contour sign, tophi, aggregates for withdrawal arm |
| Secondary | US features of gout at MPT1s | At 12 months | Double contour sign, tophi, aggregates for withdrawal arm |
| Secondary | US features of gout at MPT1s | At 18 months | Double contour sign, tophi, aggregates for withdrawal arm |
| Secondary | US features of gout at MPT1s | At 24 months | Double contour sign, tophi, aggregates for both arms |
| Secondary | US features of gout at MPT1s | At 30 months | Double contour sign, tophi, aggregates for withdrawal arm |
| Secondary | US features of gout at MPT1s | At 36 months | Double contour sign, tophi, aggregates for withdrawal arm |
| Secondary | US features of gout at knees | At 6 months | Double contour sign for withdrawal arm |
| Secondary | US features of gout at knees | At 12 months | Double contour sign for withdrawal arm |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT06956885/registered